Saudi Oncology Society clinical management guidelines for prostate cancer

Abusamra, Ashraf; Bazarbashi, Shouki; Bahader, Yasser; Kushi, Hussain; Rabbah, Dany; Bogami, Naser Al; Ghamdi, Khalid Al; Ghamdi, Abdullah Al; Balaraj, Khalid; Seyam, Raouf; Otaibi, Mohammed Al; Saeed, Eyad Al

doi:10.4103/0974-7796.78550

Cited by 3 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is an update to the previously published Saudi guidelines for the evaluation, medical, and surgical management of prostate cancer. [ 2 3 ] It is categorized according to the stage of the disease using the tumor node metastasis staging system 7 th edition. The guidelines are presented with supporting evidence level according to an article accompanying the guidelines 1 st edition, as well as, the scope, purpose, and methods of these guidelines.…”

Section: Purpose and Methodsmentioning

confidence: 99%

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer

et al. 2016

Self Cite

View full text Add to dashboard Cite

This is an update to the previously published Saudi guidelines for the evaluation, medical, and surgical management of patients diagnosed with prostate cancer. It is categorized according to the stage of the disease using the tumor node metastasis staging system 7th edition. The guidelines are presented with supporting evidence level, they are based on comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi oncology society and Saudi urological association. Considerations to the local availability of drugs, technology, and expertise have been regarded. These guidelines should serve as a roadmap for the urologists, oncologists, general physicians, support groups, and health care policy makers in the management of patients diagnosed with adenocarcinoma of the prostate to.

show abstract

Section: Purpose and Methodsmentioning

confidence: 99%

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer

et al. 2016

Self Cite

View full text Add to dashboard Cite

show abstract

“…The present guidelines are an update to the previously published Saudi Oncology Society guidelines for the evaluation, medical, and surgical management of prostate cancer. [ 2 3 4 ] More than 95% of primary prostate cancers are adenocarcinomas, so these guidelines are focused on this category of prostate tumors. This cancer is categorized according to the stage of the disease using the tumor node metastasis staging system 7 th edition.…”

Section: Introductionmentioning

confidence: 99%

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for prostate cancer 2017

et al. 2018

Self Cite

View full text Add to dashboard Cite

This is an update to the previously published Saudi guidelines for the evaluation and medical and surgical management of patients diagnosed with prostate cancer. Prostate cancer is categorized according to the stage of the disease using the tumor node metastasis staging system 7th edition. The guidelines are presented with supporting evidence levels based on a comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi Oncology Society and Saudi Urological Association. Local factors, such as availability, logistic feasibility, and familiarity of various treatment modalities, have been taken into consideration. These guidelines should serve as a roadmap for the urologists, oncologists, general physicians, support groups, and health-care policymakers in the management of patients diagnosed with adenocarcinoma of the prostate.

show abstract

“…It appears from the available data that prostate cancer has a low crude incidence rate that varies according to the geographical location, and is 2.6–3.5 per 100,000 with an increasing trend in the detection rate [1–3] . The formal use of PSA testing as a screening or early-detection tool is not currently practised in Saudi Arabia.…”

Section: Introductionmentioning

confidence: 99%

An early-detection programme for prostate cancer in Saudi men: A call from a tertiary-care centre in the Eastern province

Osman

Gomha

Harb

et al. 2014

Arab Journal of Urology

View full text Add to dashboard Cite

ObjectiveTo review the mode of presentation and clinical course of patients with prostate cancer during a specified period, as the detection rate is tending to increase, with most patients presenting at an advanced stage, and yet the overall incidence and prevalence rates are low.Patients and methodsWe retrospectively reviewed all aspects of care for patients who were diagnosed between May 2006 and July 2010.ResultsIn all, 76 men had a histologically confirmed prostatic adenocarcinoma diagnosed between May 2006 and July 2010 (mean age 71.1 years, SD 8). The median (range) prostate-specific antigen level at diagnosis was 52 (1.2–16,230) ng/mL. Of the patients, 74% had a Gleason grade of ⩾ 7 on diagnosis, and 64% had extraprostatic disease on presentation. Active surveillance was adopted in four patients, and four others were maintained on watchful waiting. Six patients had a radical prostatectomy, in one of whom it was a salvage procedure. Six patients received external-beam radical radiotherapy, five of whom had neoadjuvant, concurrent and adjuvant hormonal therapy. All remaining patients were treated primarily with androgen-deprivation therapy (ADT). Of the patients on hormonal manipulation, in 56% the cancer became castrate-resistant within the mean (SD) follow-up of 17.2 (15) months. Of patients treated primarily with ADT, 34% died. The death rate among the whole group was 23%. Both percentages include both prostate cancer-specific and non-specific mortality.ConclusionAn advanced stage of disease at presentation mandates an early-detection, hospital-based screening programme. Further research should include many more patients and be based in several centres.

show abstract

Saudi Oncology Society clinical management guidelines for prostate cancer

Abstract: In this report, guidelines for the evaluation, medical and surgical management is presented. It is categorized according to the stage of the disease using the tumor node metastasis staging system, 7th edition. The recommendations are presented with supporting level of evidence.

Cited by 3 publications

References 4 publications

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for prostate cancer 2017

An early-detection programme for prostate cancer in Saudi men: A call from a tertiary-care centre in the Eastern province

Contact Info

Product

Resources

About